PortfoliosLab logoPortfoliosLab logo
ISIN
US92536C1036
CUSIP
92536C103
IPO Date
Jul 19, 1990

Highlights

Market Cap
$64.10M
Enterprise Value
$40.11M
EPS (TTM)
-$0.78
Total Revenue (TTM)
$303.45K
Gross Profit (TTM)
-$57.90K
EBITDA (TTM)
-$8.20M
Year Range
$2.05 - $7.33
Target Price
$4.00
ROA (TTM)
-32.39%
ROE (TTM)
-40.11%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Veru Inc.

Performance

VERU Performance Chart

Veru Inc. (VERU) is up 38.3% since the beginning of the year. At $3 per share, VERU is trading 59.6% below its 52-week high of $7. Investors who bought $1,000 worth of VERU shares 5 years ago would now be looking at an investment worth $35.


Loading charts...

S&P 500 Index

Returns By Period

Veru Inc. (VERU) has returned 38.32% so far this year and -52.50% over the past 12 months. Over the last ten years, VERU has returned -13.95% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.


Veru Inc.

1D
0.34%
1M
25.96%
YTD
38.32%
6M
29.26%
1Y
-52.50%
3Y*
-36.02%
5Y*
-48.92%
10Y*
-13.95%

Benchmark (S&P 500 Index)

1D
-0.37%
1M
-0.01%
YTD
9.16%
6M
8.64%
1Y
25.22%
3Y*
19.78%
5Y*
11.99%
10Y*
13.88%
*Multi-year figures are annualized to reflect compound growth (CAGR)

VERU Monthly Returns History

Based on dividend-adjusted daily data since Feb 11, 1999, VERU's average daily return is +0.14%, while the average monthly return is +1.61%. At this rate, an investment would double in approximately 3.6 years.

Historically, 47% of months were positive and 53% were negative. The best month was Dec 2020 with a return of +184.5%, while the worst month was Mar 2023 at -70.7%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 8 months.

On a daily basis, VERU closed higher 42% of trading days. The best single day was Apr 11, 2022 with a return of +182.3%, while the worst single day was Nov 10, 2022 at -53.6%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202618.22%1.98%-14.34%1.81%5.33%24.89%38.32%
2025-14.57%-6.48%-5.70%10.53%-6.18%14.48%-16.69%-32.95%16.92%-22.37%-15.93%-13.71%-67.10%
2024-32.26%24.07%15.70%92.83%-25.19%-16.70%11.28%-12.58%-6.04%-1.78%-6.00%-8.38%-9.65%
20239.09%-31.34%-70.67%9.48%-22.05%20.20%5.88%-17.46%-30.87%25.58%5.78%-24.62%-86.36%
2022-11.71%7.50%-13.60%142.65%10.41%-12.67%7.08%26.45%-24.71%6.25%-53.59%-7.04%-10.36%
20211.97%56.69%-22.03%-17.96%-0.11%-8.61%-14.87%29.84%-4.37%-4.22%-8.20%-21.47%-31.91%

Benchmark Metrics

Veru Inc. has an annualized alpha of 36.82%, beta of 0.55, and R2 of 0.01 versus S&P 500 Index. Calculated based on daily prices since February 11, 1999.

  • This stock participated in 64.83% of S&P 500 Index downside but only 16.43% of its upside - more exposed to losses than it benefited from rallies.
  • Beta of 0.55 may look defensive, but with R2 of 0.01 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
  • R2 of 0.01 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
36.82%
Beta
0.55
0.01
Upside Capture
16.43%
Downside Capture
64.83%

Return for Risk

Risk / Return Rank

VERU ranks 21 for risk / return — below 21% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.


VERU Risk / Return Rank: 2121
Overall Rank
VERU Sharpe Ratio Rank: 2222
Sharpe Ratio Rank
VERU Sortino Ratio Rank: 2222
Sortino Ratio Rank
VERU Omega Ratio Rank: 2222
Omega Ratio Rank
VERU Calmar Ratio Rank: 1313
Calmar Ratio Rank
VERU Martin Ratio Rank: 2323
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Veru Inc. (VERU) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


VERUBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-2.50

Sortino ratioReturn per unit of downside risk

-3.17

Omega ratioGain probability vs. loss probability

0.95

1.37

-0.42

Calmar ratioReturn relative to maximum drawdown

-0.75

2.78

-3.54

Martin ratioReturn relative to average drawdown

-0.92

12.44

-13.36

Dividends

Dividend History


Veru Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Veru Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Veru Inc. was 99.12%, occurring on Mar 27, 2026. The portfolio has not yet recovered.

The current Veru Inc. drawdown is 98.76%.


Related event

Drawdown

Fall

Recovery

Underwater

2026 bear market2026
-99.12%Mar 2026
3y 7mo
3y 10moAug 2022 - now
2016 bear market2016
-91.58%Nov 2016
3y 4d4y 1mo
7y 1moOct 2013 - Dec 2020
Dot-com crash2000–2002
-83.50%Apr 2001
2y 1mo1y 2mo
3y 3moFeb 1999 - Jun 2002
Bear market2022
-79.07%Apr 2022
1y 1mo4mo 10d
1y 6moFeb 2021 - Aug 2022
2006 bear market2006
-66.00%Jul 2006
2y 4mo1y 3mo
3y 7moMar 2004 - Oct 2007

Drawdown Indicators


VERUBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-99.12%

-56.78%

-42.34%

Max Drawdown (1Y)

Largest decline over 1 year

-69.93%

-9.10%

-60.83%

Max Drawdown (3Y)

Largest decline over 3 years

-88.32%

-18.90%

-69.42%

Max Drawdown (5Y)

Largest decline over 5 years

-99.12%

-25.43%

-73.69%

Max Drawdown (10Y)

Largest decline over 10 years

-99.12%

-33.92%

-65.20%

Current Drawdown

Current decline from peak

-98.76%

-1.80%

-96.96%

Average Drawdown

Average peak-to-trough decline

-54.10%

-10.71%

-43.39%

Ulcer Index

Depth and duration of drawdowns from previous peaks

56.84%

2.03%

+54.81%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Veru Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Veru Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for VERU relative to other companies in the Biotechnology industry. Currently, VERU has a P/S ratio of 173.8. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for VERU in comparison with other companies in the Biotechnology industry. Currently, VERU has a P/B value of 1.8. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with VERU

Add Veru Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with VERU